News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
172 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (247)
2 (153)
3 (119)
4 (61)
7 (125)
8 (120)
9 (108)
10 (98)
11 (60)
13 (8)
14 (122)
15 (104)
16 (130)
17 (119)
18 (31)
21 (89)
22 (113)
23 (192)
24 (172)
25 (121)
28 (196)
29 (201)
30 (224)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
3
4
7
8
9
10
11
13
14
15
16
17
18
21
22
23
24
25
28
29
30
Startups
Novartis-, Sanofi-Backed Granite Brings $100M to Compete in Crowded I&I Space
Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address autoimmune diseases.
April 24, 2025
·
2 min read
·
Tristan Manalac
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
Merck, Bristol Myers Squibb, Sanofi and Roche had little clarity on the potential impact of President Donald Trump’s pharmaceutical tariffs but many companies are already preparing for what’s to come.
April 24, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
3 min read
Press Releases
Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025
April 24, 2025
·
6 min read
Press Releases
Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting
April 24, 2025
·
2 min read
Press Releases
Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
2 min read
Press Releases
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
April 24, 2025
·
6 min read
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
Press Releases
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
April 24, 2025
·
5 min read
Previous
2 of 18
Next